国产欧洲视频欧洲在线观看_欧美日韩不卡视频_午夜宅男永久在线观看_麻豆精品一区 久久中文视频/伊人久久影院大香线蕉/综合福利网站/成人拍拍拍免费视频网站 - 夜夜操夜夜爽

About Us

Core Team

An experienced and efficient international team from China and the United States.
  1. Dr. Hongqi Tian

    Dr. Hongqi Tian

    Founder, Chairman, Chief Executive Officer

    Dr. Hongqi Tian, the founder of Kechow Pharma, has over twenty years of experience in new drug development. During his time at Array Biopharmaceuticals Inc. in the U.S., he successfully developed four new compounds into preclinical and clinical studies. In 2014, he founded Shanghai Kechow Pharma, Inc. The company’s new anti-cancer drug, HL-085, developed with 100% independent intellectual property rights, is regarded as the best of its kind in this field. It is currently undergoing Phase I/II clinical trials simultaneously in China and the U.S. In addition, the drug has applied for more than 80 patents worldwide, with over 40 granted, and has published 40 articles.

Meanwhile, Kechow Pharma has a comprehensive R&D team that integrates discovery, clinical development, and registration. This team works closely and seamlessly together with technical experts in medicinal chemistry, biology, medicine, registration, pharmacovigilance, project management, and more. From the discovery stage to the preclinical and clinical stages, the team brings extensive practical experience in their respective fields. Currently, our growing R&D team consists of nearly 80 scientists and staff based in Shanghai, Beijing, and Tianjin, as well as international clinical and regulatory offices in the United States. Through our U.S.-based international team, we have been able to rapidly expand our international clinical development and regulatory approval operations.